Cited by 156Immunotherapy and Immune ResponsesDendrimers and Hyperbranched PolymersAdvanced Drug Delivery Systems

Differential functional effects of biomaterials on dendritic cell maturation

Open access
Park, Jaehyung, Babensee, Julia E.·2012·Acta Biomaterialia

Abstract

The immunological outcome of dendritic cell (DC) treatment with different biomaterials was assessed to demonstrate the range of DC phenotypes induced by biomaterials commonly used in combination products. Immature DCs (iDCs) were derived from human peripheral blood monocytes, and treated with different biomaterial films of alginate, agarose, chitosan, hyaluronic acid (HA), or 75:25 poly(lactic-co-glycolic acid) (PLGA) and a comprehensive battery of phenotypic functional outcomes was assessed. Different levels of functional changes in DC phenotype were observed depending on the type of biomaterial films used to treat the DCs. Treatment of DCs with PLGA or chitosan films supported DC maturation, with higher levels of DC allostimulatory capacity, pro-inflammatory cytokine release, and expression of CD80, CD86, CD83, HLA-DQ and CD44 compared with iDCs, and lower endocytic ability compared with iDCs. Alginate film induced pro-inflammatory cytokine release from DCs at levels higher than from iDCs. Dendritic cells treated with HA film expressed lower levels of CD40, CD80, CD86 and HLA-DR compared with iDCs. They also exhibited lower endocytic ability and CD44 expression than iDCs, possibly due to an insolubilized (cross-linked) form of high molecular weight HA. Interestingly, treatment of DCs with agarose film maintained the DC functional phenotype at levels similar to iDCs except for CD44 expression, which was lower than that of iDCs. Taken together, these results can provide selection criteria for biomaterials to be used in immunomodulating applications and can inform potential outcomes of biomaterials within combination products on associated immune responses as desired by the application.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.actbio.2012.06.006

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Alginate films caused a switch toward a proinflammatory environment, with a significant increase in CD83, CD86, and HLA-DQ when compared to immature DC cytokine excretion.

    “Alginate films caused a switch toward a proinflammatory environment, with a significant increase in CD83, CD86, and HLA‐DQ when compared to immature DC cytokine excretion.”

    From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [87]

    Results §3.4 reports significantly higher CD83, CD86, and HLA-DQ expression in alginate-treated DCs than in immature DCs. Results §3.6 separately reports significantly higher pro-inflammatory cytokine release. The source compares marker expression with marker expression, not with immature DC cytokine excretion as the citing sentence states. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Biomaterial type modulates the activation of DCs, where PLGA, alginate, and chitosan are able to induce DC maturation and invoke a shift toward a Th1 proinflammatory state, while HA and agarose create a more bioinert-like state in DCs, suppressing both Th1 and Th2 activation.

    “These results indicate that biomaterial type modulates the activation of DCs, where PLGA, alginate, and chitosan are able to induce DC maturation and invoke a shift toward a Th1 proinflammatory state, while HA and agarose create a more bioinert‐like state in DCs, suppressing both Th1 and Th2 activation.”

    From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [87]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Agarose caused no significant differences in phenotype compared to immature DCs other than lowered levels of CD44.

    “Agarose caused no significant differences in phenotype compared to immature DCs other than lowered levels of CD44.”

    From Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes (2024) · cites this paper as [87]

    The Abstract says agarose-treated dendritic cells had a functional phenotype similar to immature DCs, except for lower CD44 expression. However, Results §3.4 also notes slightly higher CD83 expression as an exception to the absence of significant differences in surface molecules. The claim therefore overlooks a reported difference. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • HA-treated DCs displayed a lower expression of proinflammatory cytokines, whilst also having decreased endocytic ability and CD44 expression compared to immature DCs.

    “HA‐treated DCs displayed a lower expression of the aforementioned proinflammatory cytokines, whilst also having decreased endocytic ability and CD44 expression compared to immature DCs.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 87 · Cited by 156

Authors
Park, J., & Babensee, J. E.
Affiliations
Georgia Institute of Technology (US)
Corresponding author
Babensee, Julia E.
Venue
Acta Biomaterialia
Publisher
Elsevier BV
Published
2012-10
Volume
8
Issue
10
Pages
3606-3617
ISSN
1742-7061 (ISSN-L)
OpenAlex
W2083429131
Cited by
156
References
87
Citations by year
2026: 6 · 2025: 5 · 2024: 11 · 2023: 9 · 2022: 12 · 2021: 21 · 2020: 16 · 2019: 19 · 2018: 9 · 2017: 13 · 2016: 8 · 2015: 15 · 2014: 6 · 2013: 6
FWCI
3.76
Type
journal article
Language
en
Open access
Locations
  • Acta Biomaterialia (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Science Foundation
  • Arthritis Foundation
  • National Institutes of Health
  • National Institute of Biomedical Imaging and Bioengineering (R01EB004633)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
dendritic cell maturation, alginate, agarose, chitosan, hyaluronic acid, PLGA, CD44, CD80, CD86, HLA-DR, endocytosis, inflammatory cytokines, allostimulatory capacity, immunomodulation, combination products, biomaterial selection
MeSH terms
Polylactic Acid-Polyglycolic Acid Copolymer, Histocompatibility Antigens Class II, Biocompatible Materials, Cell Adhesion, Cell Differentiation, Cell Movement, Dendritic Cells, Endocytosis, Flow Cytometry, Fluorescence, Humans, Hyaluronic Acid, Lipopolysaccharides, Polyglycolic Acid, Receptors, Cell Surface, Sepharose, Surface Properties, T-Lymphocytes, Cytokines, Apoptosis, Inflammation Mediators, Lactic Acid, Chitosan, Cell Shape, Cell Proliferation, Transcription Factor RelA, Photoelectron Spectroscopy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review